• Science and Research

  For Potential CF Therapy ARV-1801, Arrevus Secures Loan

  Posted by cystic-fibrosis-news-moderator on November 13, 2019 at 9:08 am

  

  Arrevus received a loan from the North Carolina Biotechnology Center to advance ARV-1801 for the treatment of pulmonary exacerbations in CF patients. Read the full story here.

  What do you think of this news?

  cystic-fibrosis-news-moderator replied 4 years, 5 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply